Analysis of the pH Dependence of the Neonatal Fc Receptor/Immunoglobulin G Interaction Using Antibody and Receptor Variants
The DOI matches its Crossref record.
Abstract
The neonatal Fc receptor (FcRn) binds maternal immunoglobulin G (IgG) from ingested milk in the gut (pH 6.0-6.5) and delivers it to the bloodstream of the newborn (pH 7.0-7.5). A soluble version of FcRn reproduces the physiological pH-dependent interaction with IgG, showing high-affinity binding at pH 6.0-6.5 but weak or no binding at pH 7.0-7.5. We have studied the pH dependence of the FcRn/IgG interaction using a surface plasmon resonance assay to measure kinetic and equilibrium constants. We show that the affinity of FcRn for IgG is reduced about 2 orders of magnitude as the pH is raised from 6.0 to 7.0. A hill put analysis suggests that several titrating residues participate in the pH-dependent affinity transition. Histidine side chains are likely candidate for residues that titrate between pH 6.0 and 7.0, and previous biochemical and structural work identified several histidines on the Fc portion of IgG that are located at the FcRn binding site. Using mutant IgG molecules and IgG subtype variants that differ in the number of histidines at the IgG/FcRn interface, we demonstrate that IgG histidines located at the junction between the CH2 and CH3 domains (residues 310 and 433) contribute to the pH-dependent affinity transition. Experiments with a mutant FcRn molecule show that two histidines on the FcRn heavy chain (residues 250 and 251) also contribute to the pH dependence of the FcRn/IgG interaction. There results are interpreted using the crystal structures of FcRn and an FcRn/Fc complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This characteristic is likely mediated, at least in part, via protonation of histidine residues (the only amino acid that changes between pH 5.5 and 7.4) at the CH2–CH3 domain interface of IgG (54–56).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [54]
In the citing paper
“the interaction of FcRn with IgG displays a strong pH dependence, such that high-affinity binding occurs at pH 6.0, but little or no binding occurs at physiological pH 7.4 (54).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [54]
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 317
Katz, B. A., Elrod, K., Luong, C., Rice, M. J., Mackman, R. L., Sprengeler, P. A., Spencer, J. R., Hataye, J. M., Janc, J. W., Link, J. O., et al. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4516 · Cited by 72
Ko, S., Jo, M., & Jung, S. T. (2021) · BioDrugs · doi:10.1007/s40259-021-00471-0 · Cited by 76
Targeting the Neonatal Fc Receptor for Antigen Delivery Using Engineered Fc Fragments
Mi, W., Wanjie, S., Lo, S.-T., Gan, Z., Pickl-Herk, B., Ober, R. J., & Ward, E. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7550 · Cited by 71
Jendeberg, L., Nilsson, P., Larsson, A., Denker, P., Uhlén, M., Nilsson, B., & Nygren, P.-Å. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(96)00215-3 · Cited by 67
Sakagami, M., Omidi, Y., Campbell, L., Kandalaft, L. E., Morris, C. J., Barar, J., & Gumbleton, M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-9226-0 · Cited by 68
Nixon, A. E., Chen, J., Sexton, D. J., Muruganandam, A., Bitonti, A. J., Dumont, J., Viswanathan, M., Martik, D., Wassaf, D., Mezo, A., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00176 · Cited by 66
Influence of the Isotype of the Light Chain on the Properties of IgG
Montaño, R. F., & Morrison, S. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.224 · Cited by 62
Self-citationRegulation of Immune Responses by the Neonatal Fc Receptor and Its Therapeutic Implications
Rath, T., Baker, K., Pyzik, M., & Blumberg, R. S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00664 · Cited by 63
Zhou, J., Mateos, F., Ober, R. J., & Ward, E. S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.11.014 · Cited by 65
Adamski, F. M., King, A. T., & Demmer, J. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00065-1 · Cited by 65
Recent Advances in Half-life Extension Strategies for Therapeutic Peptides and Proteins
Tan, H., Su, W., Zhang, W., Wang, P., Sattler, M., & Zou, P. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190206105232 · Cited by 64
Zhou, J., Johnson, J. E., Ghetie, V. F., Ober, R. J., & Ward, E. S. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00952-5 · Cited by 65
Next generation of multispecific antibody engineering
Kéri, D., Walker, M., Singh, I., Nishikawa, K. K., & Garcés, F. (2023) · Antibody Therapeutics · doi:10.1093/abt/tbad027 · Cited by 77
Ye, L., Liu, X., Rout, S. N., Li, Z., Yan, Y., Lu, L., Kamala, T., Nanda, N. K., Song, W., Samal, S. K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2572 · Cited by 56
Design of pH Sensitive Binding Proteins from the Hyperthermophilic Sso7d Scaffold
Gera, N., Hill, A. B., White, D. P., Carbonell, R. G., & Rao, B. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048928 · Cited by 60
Chemokine Receptor CCR3 Function Is Highly Dependent on Local pH and Ionic Strength
Dairaghi, D. J., Oldham, E. R., Bacon, K. B., & Schall, T. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28206 · Cited by 56
Getman, K. E., & Balthasar, J. P. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20297 · Cited by 56
Human placental Fcγ‐binding proteins in the maternofetal transfer of IgG
KRISTOFFERSEN, E. K. (1996) · APMIS · doi:10.1111/j.1600-0463.1996.tb05583.x · Cited by 54
Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life
Grevys, A., Frick, R., Mester, S., Flem-Karlsen, K., Nilsen, J., Foss, S., Sand, K. M. K., Emrich, T., Fischer, J. A. A., Greiff, V., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103746 · Cited by 51
Molecular Mechanisms of Acute Organophosphate Nephrotoxicity
Sobolev, V. E., Sokolova, M. O., Jenkins, R. O., & Goncharov, N. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168855 · Cited by 63
The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement
Brinkhaus, M., Pannecoucke, E., van der Kooi, E. J., Bentlage, A. E. H., Derksen, N. I. L., Andries, J., Balbino, B., Sips, M., Ulrichts, P., Verheesen, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33764-1 · Cited by 51
Gurbaxani, B. M., Dostálek, M., & Gardner, I. B. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.008 · Cited by 55
Toxin Neutralization Using Alternative Binding Proteins
Jenkins, T. P., Fryer, T., Dehli, R. I., Jürgensen, J. A., Fuglsang-Madsen, A. J., Føns, S., & Laustsen, A. H. (2019) · Toxins · doi:10.3390/toxins11010053 · Cited by 52
Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics
Zhong, X., & D’Antona, A. M. (2021) · Antibodies · doi:10.3390/antib10020013 · Cited by 46
Sprague, E. R., Martin, W. L., & Björkman, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313281200 · Cited by 45
Structural Bases of FcγR Functions
Daëron, M. (1997) · International Reviews of Immunology · doi:10.3109/08830189709045701 · Cited by 61
Maternal Transfer of Immunoglobulins into Egg Yolks of Birds
Murai, A. (2013) · The Journal of Poultry Science · doi:10.2141/jpsa.0120194 · Cited by 45
Friedrich, D., Macpherson, A., Penzel, S., Basse, N., Lecomte, F., Deboves, H., Taylor, R. D., Norman, T., Porter, J. R., Waters, L. C., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006192 · Cited by 44
Islam, A., Li, S. S., Oykhman, P., Timm-McCann, M., Huston, S. M., Stack, D., Xiang, R. F., Kelly, M. M., & Mody, C. H. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003439 · Cited by 43
Ishino, T., Wang, M., Mosyak, L., Tam, A. S. P., Duan, W., Svenson, K., Joyce, A. P., O’Hara, D. M., Lin, L., Somers, W. S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.457689 · Cited by 42
β2-microglobulin–deficient Mice Are Resistant to Bullous Pemphigoid
Liu, Z., Roopenian, D. C., Zhou, X., Christianson, G. J., Diaz, L. A., Sedmak, D. D., & Anderson, C. L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.777 · Cited by 48
Walters, B. T., Jensen, P. F., Larraillet, V., Lin, K., Patapoff, T., Schlothauer, T., Rand, K. D., & Zhang, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691568 · Cited by 42
Cell surface dynamics and cellular distribution of endogenous FcRn
D’Hooghe, L., Chalmers, A. D., Heywood, S., & Whitley, P. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182695 · Cited by 42
Iodine and Thyroid Maternal and Fetal Metabolism during Pregnancy
Mégier, C., Dumery, G., & Luton, D. (2023) · Metabolites · doi:10.3390/metabo13050633 · Cited by 52
Hardiansyah, D., & Ng, C. M. (2018) · mAbs · doi:10.1080/19420862.2018.1494479 · Cited by 46
Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
Ojaimi, Y. A., Blin, T., Lamamy, J., Gracia, M., Pitiot, A., Denevault‐Sabourin, C., Joubert, N., Pouget, J., Gouilleux‐Gruart, V., Heuzé‐Vourc'h, N., et al. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108022 · Cited by 50
Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applications
Czajkowsky, D. M., Andersen, J. T., Fuchs, A., Wilson, T. J., Mekhaiel, D., Colonna, M., He, J., Shao, Z., Mitchell, D. A., Wu, G., et al. (2015) · Scientific Reports · doi:10.1038/srep09526 · Cited by 38
FcRn expression in cancer: Mechanistic basis and therapeutic opportunities
Rudnik‐Jansen, I., & Howard, K. A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.007 · Cited by 43
Using multifocal plane microscopy to reveal novel trafficking processes in the recycling pathway
Gan, Z., Ram, S., Ober, R. J., & Ward, E. S. (2013) · Journal of Cell Science · doi:10.1242/jcs.116327 · Cited by 38
“IgG binds to FcRn at the slightly acidic pH of early endosomes, but with very low affinity at neutral pH (Raghavan et al., 1995; Popov et al., 1996).”
BackgroundOn the Perplexingly Low Rate of Transport of IgG2 across the Human Placenta
Einarsdottir, H. K., Stapleton, N. M., Scherjon, S., Andersen, J. T., Rispens, T., van der Schoot, C. E., & Vidarsson, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108319 · Cited by 38
Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization
Foss, S., Grevys, A., Sand, K. M. K., Bern, M., Blundell, P. A., Michaelsen, T. E., Pleass, R. J., Sandlie, I., & Andersen, J. T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.033 · Cited by 39
Chia, J., Louber, J., Glauser, I., Taylor, S., Bass, G., Dower, S., Gleeson, P. A., & Verhagen, A. M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.817064 · Cited by 45
Sedimentation equilibrium analysis of recombinant mouse FcRn with murine IgG1
Schuck, P., Radu, C. G., & Ward, E. S. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00093-0 · Cited by 35
Recruiting Zn2+to Mediate Potent, Specific Inhibition of Serine Proteases
Katz, B. A., & Luong, C. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3071 · Cited by 34
Zhang, J., Huang, Y., Xi, G., & Zhang, F. P. Y. (2020) · mAbs · doi:10.1080/19420862.2020.1724751 · Cited by 34
Pollastrini, J., Dillon, T. M., Bondarenko, P. V., & Chou, R. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.03.001 · Cited by 37
Béquignon, É., Dhommée, C., Angély, C., Thomas, L., Bottier, M., Escudier, E., Isabey, D., Coste, A., Louis, B., Papon, J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061379 · Cited by 35
Role of Fc Receptors as a Therapeutic Target
Masuda, A., Yoshida, M., Shiomi, H., Morita, Y., Kutsumi, H., Inokuchi, H., Mizuno, S., Nakamura, A., Takai, T., Blumberg, R. S., et al. (2009) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152809787582525 · Cited by 38
Comparison of FcRn‐ and pIgR‐Mediated Transport in MDCK Cells by Fluorescence Confocal Microscopy
Jerdeva, G. V., Tesar, D. B., Huey‐Tubman, K. E., Ladinsky, M. S., Fraser, S. E., & Björkman, P. J. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01083.x · Cited by 34
Yang, D., Giragossian, C., Castellano, S., Lasaro, M. O., Xiao, H., Saraf, H., Kenny, C. H., Rybina, I. V., Huang, Z.-F., Ahlberg, J., et al. (2017) · mAbs · doi:10.1080/19420862.2017.1359455 · Cited by 33
Application of FcRn Binding Assays to Guide mAb Development
Datta‐Mannan, A., & Wroblewski, V. J. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059089 · Cited by 32
Katz, B. A., & Cass, R. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13220 · Cited by 30
Jordan, S. C., Kucher, K., Bagger, M. A., Hockey, H., Wagner, K., Ammerman, N., & Vo, A. A. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15922 · Cited by 30
Richardson, S. I., Ayres, F., Manamela, N. P., Oosthuysen, B., Makhado, Z., Lambson, B. E., Morris, L., & Moore, P. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.733958 · Cited by 31
Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin
Ma, G., Crowley, A. R., Heyndrickx, L., Rogiers, I., Parthoens, E., Van Santbergen, J., Ober, R. J., Bobkov, V., de Haard, H., Ulrichts, P., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.176166 · Cited by 28
Ng, C. M., Loyet, K. M., Iyer, S., Fielder, P. J., & Deng, R. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.033 · Cited by 29
Glassman, P. M., Chen, Y., & Balthasar, J. P. (2015) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-015-9444-y · Cited by 29
Thorek, D. L. J., Watson, P. A., Lee, S.-G., Ku, A. T., Bournazos, S., Braun, K., Kim, K., Sjöström, K., Doran, M. G., Lamminmäki, U., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2335 · Cited by 26
Brain antibodies in the cortex and blood of people with schizophrenia and controls
Glass, L. J., Sinclair, D., Boerrigter, D., Naude, K., Fung, S. J., Brown, D. A., Catts, V. S., Tooney, P. A., O׳Donnell, M., Lenroot, R., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.134 · Cited by 28
Megalin/Cubilin-mediated Uptake of FITC-labeled IgG by OK Kidney Epithelial Cells
Nagai, J., Sato, K., Yumoto, R., & Takano, M. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-022 · Cited by 27
Ladinsky, M. S., Huey‐Tubman, K. E., & Björkman, P. J. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0093 · Cited by 26
Impact of SPR biosensor assay configuration on antibody: Neonatal Fc receptor binding data
Wang, X., McKay, P., Yee, L. T., Dutina, G., Hass, P. E., Nijem, I., Allison, D., Cowan, K. J., Lin, K., Quarmby, V. E., et al. (2016) · mAbs · doi:10.1080/19420862.2016.1261774 · Cited by 32
Fc Engineering: Serum Half-Life Modulation Through FcRn Binding
Olafsen, T. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-974-7_31 · Cited by 28
Quantitative methods for developing Fc mutants with extended half‐lives
Kamei, D. T., Lao, B. J., Speed, M. A., Deshpande, R. R., Xu, H., Tidor, B., & Lauffenburger, D. A. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20624 · Cited by 30
Muns, J. A., Montserrat, V., Houthoff, H.-J., van der Schilden, K., Zwaagstra, O., Sijbrandi, N. J., Merkul, E., & van Dongen, G. A. M. S. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.206672 · Cited by 27
Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease
Fitzpatrick, E. A., Wang, J., & Strome, S. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00496 · Cited by 26
Trastoy, B., Du, J. J., Cifuente, J. O., Rudolph, L., García-Alija, M., Klontz, E. H., Deredge, D. J., Sultana, N. A., Huynh, C. G., Flowers, M. W., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37215-3 · Cited by 28
Feng, Y., Gong, R., & Dimitrov, D. S. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.03.012 · Cited by 26
The role of Fc receptors in HIV infection and vaccine efficacy
Cocklin, S. L., & Schmitz, J. E. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000051 · Cited by 25
Ellinger, I., Stefanescu, A., Hunziker, W., & Fuchs, R. (1997) · Biochemical Journal · doi:10.1042/bj3270585 · Cited by 28
Protein-Protein Docking with Dynamic Residue Protonation States
Kilambi, K. P., Reddy, K., & Gray, J. J. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004018 · Cited by 26
Li, T. R., & Balthasar, J. P. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.10.065 · Cited by 24
Azevedo, C., Pinto, S., Benjakul, S., Nilsen, J., Santos, H. A., Traverso, G., Andersen, J. T., & Sarmento, B. F. C. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.016 · Cited by 29
Maternal brain reactive antibodies profile in autism spectrum disorder: an update
Bagnall-Moreau, C., Spielman, B. P., & Brimberg, L. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02335-3 · Cited by 30
Kats, M., Richberg, P. C., & Hughes, D. E. (1997) · Analytical Chemistry · doi:10.1021/ac9606517 · Cited by 23
Traxlmayr, M. W., Wozniak‐Knopp, G., Antes, B., Stadlmayr, G., Rüker, F., & Obinger, C. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.06.042 · Cited by 22
Fusion of engineered albumin with factor IX Padua extends half‐life and improves coagulant activity
Lombardi, S., Aaen, K. H., Nilsen, J., Ferrarese, M., Gjølberg, T. T., Bernardi, F., Pinotti, M., Andersen, J. T., & Branchini, A. (2021) · British Journal of Haematology · doi:10.1111/bjh.17559 · Cited by 24
Okamoto, M., Sasaki, R., Ikeda, K., Doi, K., Tatsumi, F., Oshima, K., Kojima, T., Mizushima, S., Ikegami, K., Yoshimura, T., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1305587 · Cited by 26
Toward a Combinatorial Approach for the Prediction of IgG Half-Life and Clearance
Goulet, D. R., Watson, M. J., Tam, S. H., Zwolak, A., Chiu, M. L., Atkins, W. M., & Nath, A. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081893 · Cited by 24
Pharmacokinetics of Antibodies and Immunotoxins in Mice and Humans
Ghetie, V. F., Ward, E. S., & Vitetta, E. S. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-734-5_29 · Cited by 21
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress
Gjølberg, T. T., Mester, S., Calamera, G., Telstad, J. S., Sandlie, I., & Andersen, J. T. (2025) · BioDrugs · doi:10.1007/s40259-025-00708-2 · Cited by 20
Surrogate approaches in development of monoclonal antibodies
Bornstein, G. G., Klakamp, S. L., Andrews, L., Boyle, W. J., & Tabrizi, M. A. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.014 · Cited by 20
Schade, R., & Chacana, P. A. (2007) · Springer eBooks · doi:10.1007/978-3-540-37885-3_5 · Cited by 21
Computational determination of the structure of rat fc bound to the neonatal fc receptor
Weng, Z., Gulukota, K., Vaughn, D. E., Björkman, P. J., & DeLisi, C. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2020 · Cited by 20
Stapleton, N. M., Armstrong-Fisher, S. S., Andersen, J. T., van der Schoot, C. E., Porter, C., Page, K., Falconer, D. W., de Haas, M., Williamson, L. M., Clark, M., et al. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.01.006 · Cited by 23
Demarest, S. J., Hopp, J., Chung, J., Hathaway, K., Mertsching, E., Cao, X., George, J., Miatkowski, K., LaBarre, M. J., Shields, M. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605190200 · Cited by 19
Gitlin, I., Carbeck, J. D., & Whitesides, G. M. (2006) · Angewandte Chemie · doi:10.1002/ange.200502530 · Cited by 20
Dai, H. J., & Krull, I. S. (1998) · Journal of Chromatography A · doi:10.1016/s0021-9673(98)00226-x · Cited by 19
FcRn regulates antigen presentation in dendritic cells downstream of DEC205-targeted vaccines
Macri, C., Paxman, M., Jenika, D., Lin, X. P., Elahi, Z., Gleeson, P. A., Caminschi, I., Lahoud, M. H., Villadangos, J. A., & Mintern, J. D. (2024) · npj Vaccines · doi:10.1038/s41541-024-00854-8 · Cited by 19
Oldham, R. J., Mockridge, C. I., James, S., Duriez, P. J., Chan, H. T. C., Cox, K. L., Pitic, V. A., Glennie, M. J., & Cragg, M. S. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000619 · Cited by 20
O'Shannessy, D. J., Bendas, K., Schweizer, C., Wang, W., Albone, E. F., Somers, E. B., Weil, S. C., Meredith, R. K., Wustner, J., Grasso, L., et al. (2017) · Genomics · doi:10.1016/j.ygeno.2017.04.006 · Cited by 19
Expression of soluble and functional human neonatal Fc receptor in Pichia pastoris
Lee, C., Choi, D.-K., Choi, H., Song, M.-Y., & Kim, Y. (2009) · Protein Expression and Purification · doi:10.1016/j.pep.2009.12.004 · Cited by 18
Zhong, E. H., Ledderose, C., Mello, P. D. A., Enjyoji, K., Lunderberg, J. M., JUNGER, W. G., & Robson, S. C. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00430.2020 · Cited by 17
Suzuki, T., Hashii, N., Tada, M., & Ishii‐Watabe, A. (2021) · mAbs · doi:10.1080/19420862.2021.1923366 · Cited by 18
Szikora, B., Hiripi, L., Bender, B., Kacskovıcs, I., & Iliás, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185662 · Cited by 17
Magistrelli, G., Malinge, P., Anceriz, N., Desmurs, M., Venet, S., Calloud, S., Daubeuf, B., Kosco‐Vilbois, M. H., & Fischer, N. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.09.002 · Cited by 17
Surface Plasmon Resonance for Therapeutic Antibody Characterization
Davidoff, S. N., Ditto, N. T., Brooks, A. E., Eckman, J. W., & Brooks, B. D. (2015) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-2617-6_3 · Cited by 17
Cooper, P. R., Kliwinski, C. M., Perkinson, R. A., Ragwan, E., Mabus, J. R., Powers, G. D., Dorai, H., Giles-Komar, J. M., & Hornby, P. J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00225 · Cited by 16
Recombinant human lactoferrin-Fc fusion with an improved plasma half-life
Shiga, Y., Oshima, Y., Kojima, Y., Sugimoto, A., Tamaki, N., Murata, D., Takeuchi, T., & Sato, A. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.11.005 · Cited by 16
Shen, Y., Li, H., Zhao, L., Li, G., Chen, B., Guo, Q., Gao, B., Wu, J., Yang, T., Jin, L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183326 · Cited by 17
Metadata
- Authors
- Raghavan, M., Bonagura, V. R., Morrison, S. L., & Bjorkman, P. J.
- Affiliations
- California Institute of Technology (US)
- Northwell Health (US)
- University of California, Los Angeles (US)
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1995-11-01
- Volume
- 34
- Issue
- 45
- Pages
- 14649-14657
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2065219066
- Cited by
- 317
- References
- 0
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 10 · 2023: 15 · 2022: 12 · 2021: 15 · 2020: 13 · 2019: 8 · 2018: 18 · 2017: 13 · 2016: 8 · 2015: 17 · 2014: 20 · 2013: 13 · 2012: 15
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca016858-25)
- National Cancer Institute (CA-16858)
- National Institute of Allergy and Infectious Diseases (AI29470)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal health and immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- neonatal Fc receptor, IgG, pH-dependent binding, ligand-receptor interactions, binding affinity, maternal IgG transfer
- MeSH terms
- Antibodies, Monoclonal, Binding Sites, Computer Graphics, Histidine, Humans, Hydrogen-Ion Concentration, Immunoglobulin G, Infant, Newborn, Kinetics, Models, Molecular, Protein Binding, Receptors, Fc, Biosensing Techniques, Mutagenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.